Jeffrey Boyd

Sloan-Kettering Institute For Cancer Res

$5,544,717

Attributed

$5,544,717

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.3M · FY2005–13

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

Funding mix

By agency

NIH$9,975,629 · 5

By mechanism

P50$4,430,912 · 1

R01$2,882,180 · 2

P01$1,657,299 · 1

U01$1,005,238 · 1

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Institute For Cancer Res

Same institution · by research overlap

Stephen David Nimer$17,329,022
Lorraine J Gudas$39,938,263
Sara H Olson$2,836,644
Pier Paolo Pandolfi$54,825,346
David R Spriggs$13,987,182

Others in their field

Top investigators on “Neoplasm /Cancer Genetics”

Gregory H Reaman · National Childhood Cancer Foundation$112,559,481
Charles A Coltman · Southwest Oncology Group$46,831,444
Samuel A Wells · Duke University$32,148,803
David Sidransky · Johns Hopkins University$27,906,864
Brian E Henderson · University Of Southern California$27,493,155
Bruce W Stillman · Cold Spring Harbor Laboratory$22,532,365

Research focus

Neoplasm /Cancer GeneticsFemaleWomen'S HealthOvary NeoplasmsNeoplasm /Cancer Classification /StagingComplementary DnaWestern BlottingsMicroarray TechnologyNorthern BlottingsHuman TissueImmunocytochemistryPolymerase Chain ReactionMolecular GeneticsTissue Resource /RegistryCooperative StudyClinical ResearchNucleic Acid SequenceFluorescent In Situ HybridizationGene ExpressionNeoplasm /Cancer Relapse /RecurrenceResponseMolecularMalignant NeoplasmsBase